Soleus Capital Management, L.P. Galapagos Nv Transaction History

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$51.32 - $68.5 $5.07 Million - $6.77 Million
-98,800 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$47.03 - $57.12 $775,995 - $942,480
-16,500 Reduced 14.31%
98,800 $5.45 Million
Q3 2021

Nov 15, 2021
BUY
$52.17 - $70.2 $6.02 Million - $8.09 Million
115,300 New
115,300 $6.07 Million

Others Institutions Holding GLPG

# of Institutions
85
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.8B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email